Latanoprost in eyes with uveitic glaucoma

Article

Efficacy and safety of latanoprost in eyes with uveitic glaucoma

Efficacy and safety of latanoprost in eyes with uveitic glaucoma, from Graefe's Archive for Clinical and Experimental Ophthalmology.

Please click here to read the article.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Recent Videos
Harvey Uy, MD, DPBO, FVRSP, speaks about artificial intelligence (AI) and optical coherence tomography (OCT) at the 2025 European Society of Retina Specialists (EURETINA) Congress.
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
Related Content
An image of an iris placed over a digital interlay. Concept image for BVI Medical and VirtuaLens new technologies at European Society of Cataract and Refractive Surgeons meeting in Copenhagen, Denmark. (Image credit: ©spainter_vfx/AdobeStock)

BVI, VirtuaLens will showcase new technologies at ESCRS 2025

Kassi Filkins
September 12th 2025
Article
PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

September 12th 2025
Podcast
The Intercil Uveal Spacer from Ciliatech, which recently obtained a CE mark, does not penetrate the anterior of the eye. All images courtesy of Ciliatech.

Ciliatech leadership comments on CE mark for novel glaucoma device

Hattie Hayes;Kassi Filkins
September 12th 2025
Article
PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

September 12th 2025
Podcast
EMA grants Orphan designations to MCO-010 across 5 categories of retinal dystrophies

EMA grants Orphan designations to MCO-010 across 5 categories of retinal dystrophies

Sydney M Crago
September 12th 2025
Article
A movie theatre with empty seats. The screen has reels of film negatives, with a blue tint, and the words "Coming Soon" in large yellow letters. Image credit: Created with Canva. Components via Photology2000 and Ron Lach, Pexels.

EURETINA industry previews: Beacon Therapeutics, Nanoscope Therapeutics and Valitor

Kassi Filkins
September 12th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.